short hydration

PROCEDURE3 trials

Sponsors

Nagoya University graduate scool of medicine, department of respiratory medicine, Mahidol University, Division of Medical Oncology, Department of Internal Medicine, Buddhasothorn Hospital

Conditions

Cis-Platinum NephropathyLung cancerRenal Insufficiencycancer patients who treated with intermediate to high dose cisplatin in outpatient. Short hydration cisplatin Nephrotoxicity chemoprevention

Phase 2

Efficacy of Short Hydration for Intermediate to High-Dose Cisplatin-Based Chemotherapy for Outpatient

Active, not recruitingTCTR20210128002

Division of Medical Oncology, Department of Internal Medicine, Buddhasothorn Hospitalcancer patients who treated with intermediate to high dose cisplatin in outpatient. Short hydration cisplatin Nephrotoxicity chemoprevention

Start: 2019-12-23Target: 13Updated: 2026-08-03

Unknown Phase

A feasibility study of short hydration regimen for lung cancer patients receiving cisplatin-based chemotherapy

Active, not recruitingJPRN-UMIN000011687

Nagoya University graduate scool of medicine, department of respiratory medicineLung cancer

Start: 2013-10-01Target: 40Updated: 2026-06-29

Safety of Short Hydration Method for Cisplatin Administration Compared With Conventional Hydration

Mahidol UniversityCis-Platinum Nephropathy, Renal Insufficiency

Start: 2023-03-07End: 2025-03-07Target: 100Updated: 2023-06-01

Related Papers

Efficacy of Short Hydration for Intermediate to High-Dose Cisplatin-Based Chemotherapy for Outpatients: SHORTCIS Trial.

2022-10-013 citations